日清食品(01475.HK)控股股东首三财季中国业务销售总额按年增13.8%
日清食品(01475.HK)控股股东日本日清公布,截至去年底止首三财季业绩,中国业务销售总额录361.56亿日圆(下同),按年增长13.8%;销售给第三方则录353.32亿元,按年增长13.4%。经营收入40.17亿元,按年增长32.2%。
公司指,高增值面市场持续在中国大陆扩张。集团积极扩展其地域销售面积并强化其合味道品牌。此外,2019冠状病毒病爆发後,宅经济令即食面的需求上涨。在此环境下,有赖於合味道品牌及出前一丁品牌在中国大陆及香港的强劲销售量表现,销售额按年增加。溢利按年增加乃由於中国大陆及香港销售量增加,以及来自销售量增加相关的成本降低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.